Trademark: 88581014
Word
ENLIGHTEN HEALTH
Status
Dead
Status Code
606
Status Date
Monday, July 4, 2022
Serial Number
88581014
Mark Type
4000
Filing Date
Thursday, August 15, 2019
Published for Opposition
Tuesday, April 6, 2021
Abandoned Date
Monday, July 4, 2022

Trademark Owner History

Classifications
36 Providing a database featuring information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices; financial administration of patient reimbursement programs
35 Business consultancy, business management consultancy, business strategy advisory and marketing services for pharmaceutical, medical device, food and healthcare companies; business consulting services, business strategy advisory services and marketing services relating to the development, formulation and testing of pharmaceuticals, bio-technology products and medical devices; business consulting services, business strategy advisory services and marketing services relating to conducting of clinical trials; business consulting services, business strategy advisory services and marketing services relating to the commercialization of pharmaceutical products, bio-technological products or medical devices; business consulting services, business strategy advisory services and marketing services relating to lead candidate drug optimization; business organization consultancy; retail store and wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; personnel recruitment; business project management services in the fields of clinical and non-clinical programs, clinical and non-clinical drug development and research studies, clinical and non-clinical trials or proof of concept trials; business consultation in the nature of design and development of market access strategies; implementation of market access strategies and processes on behalf of others for business purposes; business data analysis and reporting, review and analysis of medical and clinical data for third parties and providing a report on the meaning of such data to third parties for business cost analysis; business consultation services in the market authorization of drugs; commercial administration of the licensing of the goods and services of others; compilation of information into computer databases; business advisory services, business consultancy services, business data analysis, business information services, business management consulting, business strategy services, market research, marketing services, database management, and business project management services, all in the fields of medical testing, testing for forensic purposes, testing for quality control purposes, genetic testing, clinical and analytical testing, disease, medical care, healthcare, pharmaceuticals, medical devices, biochemicals, and biotechnology; regulatory submission management, namely, assisting others in preparing and filing applications with governmental regulatory bodies for approval of new drugs and medical devices; business management services, namely, supply and demand forecasting drug supplies for clinical trials; business management services, namely, recruiting patients and volunteers for clinical trials; business administration of patient reimbursement programs; Business services provided to the health care industry, namely, consulting services, market intelligence, data collection, data submission and patient management; holding company services, namely, providing ownership cost analyses, financial control audits, and business information reporting services for subsidiaries and affiliates; holding company services, namely, providing business management and business administration services for subsidiaries and affiliates
45 Advisory services relating to regulatory compliance in the fields of pharmaceuticals and medical devices; monitoring of regulatory compliance in non-clinical and clinical pharmaceutical and medical device trials; investigation of assets, preparation and review of reports and assessments for regulatory purposes; providing information and advice regarding regulatory compliance; regulatory compliance consulting in the fields of pharmaceuticals and medical devices; regulatory compliance consulting in the field of obtaining government authorization to market pharmaceuticals and medical devices
"HEALTH"

Trademark Events
Jul 5, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 4, 2022
Abandonment - No Use Statement Filed
Dec 3, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 1, 2021
Sou Extension 1 Granted
Dec 1, 2021
Sou Extension 1 Filed
Dec 1, 2021
Sou Teas Extension Received
Jun 1, 2021
Noa E-Mailed - Sou Required From Applicant
Apr 6, 2021
Official Gazette Publication Confirmation E-Mailed
Apr 6, 2021
Published For Opposition
Mar 17, 2021
Notification Of Notice Of Publication E-Mailed
Mar 1, 2021
Approved For Pub - Principal Register
Feb 17, 2021
Teas/Email Correspondence Entered
Feb 17, 2021
Correspondence Received In Law Office
Feb 17, 2021
Assigned To Lie
Nov 13, 2020
Teas Response To Office Action Received
May 14, 2020
Notification Of Non-Final Action E-Mailed
May 14, 2020
Non-Final Action E-Mailed
May 14, 2020
Non-Final Action Written
Mar 30, 2020
Teas/Email Correspondence Entered
Mar 30, 2020
Correspondence Received In Law Office
Mar 30, 2020
Teas Response To Office Action Received
Oct 5, 2019
Notification Of Non-Final Action E-Mailed
Oct 5, 2019
Non-Final Action E-Mailed
Oct 5, 2019
Non-Final Action Written
Sep 28, 2019
Assigned To Examiner
Aug 31, 2019
New Application Office Supplied Data Entered
Aug 19, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24